Literature DB >> 9427509

Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia.

J D Delcroix1, D R Tomlinson, P Fernyhough.   

Abstract

The effect of sensory neurone axotomy on the level of retrograde axonal transport of nerve growth factor (NGF) was studied in the sciatic nerve of age-matched normal and 8-week streptozocin-diabetic rats. In normal rats a 10-day sciatic nerve crush induced a 41% decrease in transported NGF, however, axotomy of sensory neurones of diabetic rats did not significantly effect the already deficient levels of NGF undergoing retrograde transport. At first sight, this result indicated that transported NGF levels in the sciatic nerve of diabetic rats are at a residual level due to deficient availability of target-derived NGF. To confirm this, the relationship of the transported NGF to the level of sensory neurone expression of the NGF receptor proteins was analysed. Western blots of L4 and L5 dorsal root ganglia (DRG) homogenates revealed no effect of axotomy and/or diabetes on the levels of the 145-kDa tyrosine kinase form of trkA. However, the expression of p75LNTR protein in the intact DRG was reduced in diabetic compared with normal rats (56%; P < 0.01), and axotomy reduced the levels in the ipsilateral ganglia of normal but not diabetic rats - as seen for NGF axonal transport. Reductions in retrograde axonal transport of NGF in both diabetes and/or axotomy were associated with the levels of p75LNTR within the lumbar DRG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427509     DOI: 10.1016/s0169-328x(97)00215-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

Review 1.  Regulation of neurotrophin signaling in aging sensory and motoneurons: dissipation of target support?

Authors:  B Ulfhake; E Bergman; E Edstrom; B T Fundin; H Johnson; S Kullberg; Y Ming
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

Review 2.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

3.  Nuclear factor-kappaB activation in axons and Schwann cells in experimental sciatic nerve injury and its role in modulating axon regeneration: studies with etanercept.

Authors:  Darrell Smith; Christopher Tweed; Paul Fernyhough; Gordon W Glazner
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

Review 4.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

5.  The role of the p75 neurotrophin receptor in the morphology of dorsal root ganglion cells in streptozotocin diabetic mice: effects of sciatic nerve crush.

Authors:  Y Jiang; J Jakobsen
Journal:  Diabetologia       Date:  2004-09-09       Impact factor: 10.122

6.  Animal models and biomarkers of neuropathy in diabetic rodents.

Authors:  A S Shaikh; R S Somani
Journal:  Indian J Pharmacol       Date:  2010-06       Impact factor: 1.200

7.  Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface.

Authors:  Damien Colas; Annalisa Manca; Jean-Dominique Delcroix; Philippe Mourrain
Journal:  Front Neurosci       Date:  2014-02-11       Impact factor: 4.677

8.  Failure to Upregulate the RNA Binding Protein ZBP After Injury Leads to Impaired Regeneration in a Rodent Model of Diabetic Peripheral Neuropathy.

Authors:  James I Jones; Christopher J Costa; Caitlin Cooney; David C Goldberg; Matthew Ponticiello; Melanie W Cohen; Wilfredo Mellado; Thong C Ma; Dianna E Willis
Journal:  Front Mol Neurosci       Date:  2021-12-07       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.